About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Tele-Harm Reduction

Tele-Harm Reduction

NCT05208697·3 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Miami

With

National Institute on Drug Abuse (NIDA)

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

age 18 or older
able to speak English
enrolled in IDEA Miami or IDEA Tampa SSPs
injection drug use in past 12 months by self-report
willing and able to sign informed consent, provide locator information and medical records release
testing reactive for HIV by rapid test
HIV RNA\>200 copies/ml as determined by on-site labs or abstracted medical records (result within 3 months of randomization date)

You may not be if

testing HIV negative via rapid test
receipt of THR intervention in the past 6 months
inability to provide informed consent
planning to leave the area within 12 months
Principal or site investigator discretion
currently in prison or jail
Enrollment in Clinical Trials Network 121

The record

StatusCompleted

PhaseNo phase

Taking part100

StartedOct 2022

UpdatedSep 9, 2026

Conditions

IV Drug Usage HIV Infections Hepatitis C

Where3

Care Resource The SPOT
Fort Lauderdale, Florida, United States
University of Miami
Miami, Florida, United States
University of South Florida
Tampa, Florida, United States